Hephaï, a French start-up developing an AI-based digital education platform, today announces that it has filed a patent application. This patent covers the software technology used in its digital education tool, which is designed to ...
Amgen (NASDAQ:AMGN) today announced its partner AstraZeneca (NASDAQ:AZN) submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for tezepelumab, a potential first-in-class medicine in severe asthma. The submission is supported ...
Research presented at the Respiratory Drug Delivery (RDD) 2021 conference suggests that inhalers using acoustic technology developed in the UK could provide a viable alternative to expensive electronic smart inhalers for the millions of respiratory ...
